Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00067431 · ClinicalTrials.gov registry record · Phase 3
A Study of the Safety and Efficacy of Depakote Sprinkle Capsules in the Treatment of Partial Seizures in Children
A Phase 3 study, sponsored by Abbott.
- Terminated
- Registry status
- Phase 3
- Development phase
- 300
- Enrollment target
NCT00067431 is a Phase 3 study that was terminated before completion, run by Abbott. The registered enrollment target is 300 participants.
The verdict
NCT00067431, a Phase 3 study, was terminated before completion, sponsored by Abbott.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 300 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the safety and efficacy of two concentration ranges of valproate using Depakote Sprinkle Capsules as adjunctive therapy in the treatment of partial seizures, with or without secondary generalization, in children 3-10 years.
Interventions
- DRUG Divalproex Sodium (Depakote® Sprinkle Capsules)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2003-07 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00067431
The ClinicalTrials.gov registry entry for NCT00067431 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott, which has 181 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Divalproex Sodium (Depakote® Sprinkle Capsules) is the first listed.
NCT00067431 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00067431 about?
NCT00067431 is a clinical study titled "A Study of the Safety and Efficacy of Depakote Sprinkle Capsules in the Treatment of Partial Seizures in Children". The purpose of this study is to compare the safety and efficacy of two concentration ranges of valproate using Depakote Sprinkle Capsules as adjunctive therapy in the treatment of partial seizures, with or without secondary generalization, in children 3-10 years.
What is the current status of trial NCT00067431?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 300 participants. The study started on 2003-07.
What interventions are being tested in trial NCT00067431?
The interventions under investigation include: Divalproex Sodium (Depakote® Sprinkle Capsules) (DRUG).
Who is sponsoring clinical trial NCT00067431?
This trial is sponsored by Abbott, which has 181 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.